Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

California approves CVS Health-Aetna deal

Another regulator has cleared the way for the $69 billion deal between CVS Health and Aetna, as California approved the deal—with conditions.

Thumbnail

Housing reimbursement may be on the way for Medicaid

Expanded benefits could include paying for housing among Medicaid beneficiaries, according to HHS Secretary Alex Azar, who spoke about the impact of social determinants of health during a speech with the Hatch Foundation for Civility and Solutions on Nov. 14.

Thumbnail

Where Medicare Advantage will cost the least in 2019

Healthcare costs around the country vary across settings and services, and the same is true for Medicare Advantage, which is expected to grow to 22.6 million members in 2019.

Thumbnail

Mayo Clinic receives $200M gift

A philanthropist has given $200 million to Mayo Clinic in what is the largest-ever donation to the nonprofit hospital system.

NYT: Hospital mergers lead to higher costs for patients

On the surface, hospital mergers may seem like an opportunity to create benefits for consumers, including more resources for top-notch care and lower costs. However, cheaper prices aren’t a likely outcome, according to an analysis by The New York Times.

Thumbnail

CMS to allow Medicaid mental health demonstrations

CMS sent state Medicaid directors an email on Nov. 13 announcing new opportunities to design service delivery systems for treating mental health. The announcement eases previous prohibitions against using Medicaid funding to pay for short-term residential treatment in an institution for mental disease.

Thumbnail

Envision reaches contract agreement with Cigna

Envision Healthcare has reached a new statewide agreement with Cigna Healthcare of Arizona. The multiyear agreement ensures Envision’s clinicians are in-network.

Thumbnail

FDA will strengthen expanded access program for non-approved treatments

FDA Commissioner Scott Gottlieb, MD, has signaled that the agency will strengthen its expanded access (EA) program to enable more patients to access investigational medical products and treatments for serious or life-threatening diseases.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup